Bnp Paribas Arbitrage, Snc »

Oncternal Therapeutics shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Oncternal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-12-31 $96 182 0.53
2024-09-30 $240 182 1.32
2024-06-30 $1.4k 182 7.60
2024-03-31 $1.6k 182 9.00

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
Amazon.com Equity (AMZN)
Meta Platforms Equity (META)
Tesla Equity (TSLA)
Alphabet Equity (GOOGL)
JPMorgan Chase & Co Equity (JPM)
Broadcom Equity (AVGO)
State Street SPDR S&P Biotech ETF Fund (XBI)
Alphabet Equity (GOOG)
State Street SPDR S&P 500 ETF Trust Fund (SPY)
Cisco Systems Equity (CSCO)
Micron Technology Equity (MU)
Advanced Micro Devices Equity (AMD)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Oncternal Therapeutics

Bnp Paribas Arbitrage, Snc
Union Bancaire Privee, UBP SA

View all funds holding Oncternal Therapeutics